BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34298947)

  • 1. High-Throughput Screen Detects Calcium Signaling Dysfunction in Hutchinson-Gilford Progeria Syndrome.
    Fafián-Labora JA; Morente-López M; de Toro FJ; Arufe MC
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next-Generation Sequencing and Quantitative Proteomics of Hutchinson-Gilford progeria syndrome-derived cells point to a role of nucleotide metabolism in premature aging.
    Mateos J; Fafián-Labora J; Morente-López M; Lesende-Rodriguez I; Monserrat L; Ódena MA; Oliveira E; de Toro J; Arufe MC
    PLoS One; 2018; 13(10):e0205878. PubMed ID: 30379953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progeria of stem cells: stem cell exhaustion in Hutchinson-Gilford progeria syndrome.
    Halaschek-Wiener J; Brooks-Wilson A
    J Gerontol A Biol Sci Med Sci; 2007 Jan; 62(1):3-8. PubMed ID: 17301031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hutchinson-Gilford progeria syndrome.
    Pollex RL; Hegele RA
    Clin Genet; 2004 Nov; 66(5):375-81. PubMed ID: 15479179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.
    Saxena S; Kumar S
    Geroscience; 2020 Apr; 42(2):467-494. PubMed ID: 32048129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical screening identifies ROCK as a target for recovering mitochondrial function in Hutchinson-Gilford progeria syndrome.
    Kang HT; Park JT; Choi K; Choi HJC; Jung CW; Kim GR; Lee YS; Park SC
    Aging Cell; 2017 Jun; 16(3):541-550. PubMed ID: 28317242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford progeria syndrome.
    Köhler F; Bormann F; Raddatz G; Gutekunst J; Corless S; Musch T; Lonsdorf AS; Erhardt S; Lyko F; Rodríguez-Paredes M
    Genome Med; 2020 May; 12(1):46. PubMed ID: 32450911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential stem cell aging kinetics in Hutchinson-Gilford progeria syndrome and Werner syndrome.
    Wu Z; Zhang W; Song M; Wang W; Wei G; Li W; Lei J; Huang Y; Sang Y; Chan P; Chen C; Qu J; Suzuki K; Belmonte JCI; Liu GH
    Protein Cell; 2018 Apr; 9(4):333-350. PubMed ID: 29476423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging candidate treatment strategies for Hutchinson-Gilford progeria syndrome.
    Strandgren C; Revêchon G; Sola-Carvajal A; Eriksson M
    Biochem Soc Trans; 2017 Dec; 45(6):1279-1293. PubMed ID: 29127216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A homozygous ZMPSTE24 null mutation in combination with a heterozygous mutation in the LMNA gene causes Hutchinson-Gilford progeria syndrome (HGPS): insights into the pathophysiology of HGPS.
    Denecke J; Brune T; Feldhaus T; Robenek H; Kranz C; Auchus RJ; Agarwal AK; Marquardt T
    Hum Mutat; 2006 Jun; 27(6):524-31. PubMed ID: 16671095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hutchinson-Gilford progeria syndrome: clinical and molecular analysis in an African patient].
    Mutesa L; Pierquin G; Cwiny-Ay N; Buzizi P; Bours V
    Rev Med Liege; 2007 Mar; 62(3):155-8. PubMed ID: 17511383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the Hutchinson-Gilford Progeria Mutation Leads to Aberrant Dentin Formation.
    Choi H; Kim TH; Jeong JK; Strandgren C; Eriksson M; Cho ES
    Sci Rep; 2018 Oct; 8(1):15368. PubMed ID: 30337599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of treatment strategies for Hutchinson-Gilford Progeria syndrome.
    Harhouri K; Frankel D; Bartoli C; Roll P; De Sandre-Giovannoli A; Lévy N
    Nucleus; 2018 Jan; 9(1):246-257. PubMed ID: 29619863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells.
    Liu C; Arnold R; Henriques G; Djabali K
    Cells; 2019 Oct; 8(10):. PubMed ID: 31635416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hutchinson-Gilford progeria syndrome: clinical findings in three patients carrying the G608G mutation in LMNA and review of the literature.
    Mazereeuw-Hautier J; Wilson LC; Mohammed S; Smallwood D; Shackleton S; Atherton DJ; Harper JI
    Br J Dermatol; 2007 Jun; 156(6):1308-14. PubMed ID: 17459035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced SRSF5 Protein Expression Reinforces Lamin A mRNA Production in HeLa Cells and Fibroblasts of Progeria Patients.
    Vautrot V; Aigueperse C; Oillo-Blanloeil F; Hupont S; Stevenin J; Branlant C; Behm-Ansmant I
    Hum Mutat; 2016 Mar; 37(3):280-91. PubMed ID: 26670336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.